Abstract:Hybrid hydrogels with good biocompatibility have practical applications in the field of drug delivery. However, it remains challenging to formulate the hybrid hydrogels for sustained drug release by regulating their pore size and degradation rates. Herein, a hybrid chitosan-alginate hydrogel (superabsorbent) was synthesized using maleic acid as a cross-linker and acrylamide as a grafting agent. The composite hydrogel exhibited a good swelling percentage of 1246% (at pH 10), analysed using response surface methodology (RSM). The hybrid hydrogel system was hemocompatible as well as biocompatible and utilized for drug delivery applications. Pantoprazole sodium was taken as a model drug and it was loaded in the superabsorbent using the swelling diffusion method. The composite hydrogel showed excellent encapsulation efficiency for pantoprazole sodium (99.74%). The intermolecular interactions between hydrogel and drug were examined using different analytical techniques including XRD (X-Ray Diffraction), FTIR (Fourier transform infrared), SEM (Scanning electron microscope), thermal analysis and EDX (Energy dispersive X-ray) mapping. The swelling percentage of the drug loaded hydrogel under simulated gastrointestinal conditions was recorded as 917.80% (at stomach pH 1.2) and 756.95% (at intestinal pH 7.4) where protonation/deprotonation of the drug in the hydrogel matrix played an important role. In vitro drug release from the drug-loaded hydrogel was sustained up to 10 days and correlated with its swelling tendency, displaying higher release profiles at pH 1.2 (99.69%) than at pH 7.4 (72.16%). The pore volume of hydrogel was tuned varying the cross-linker amount during synthesis. BET (Brunauer-Emmett-Teller) results revealed that the pore volume of the hydrogel varied between 0.01775–0.01327 cm 3 /g for the cross-linker amount between 0.18–0.26 g, respectively. The impact of various factors including amount of cross-linker, pore volume, and drug loading percentage on drug release at pH 1.2 and 7.4 was studied statistically as well as experimentally and these factors significantly controlled the drug release percentage. The drug release from the hydrogel followed the Makoid-Banakar model with Fickian diffusion mechanism. The synthesized composite chitosan-alginate hydrogel could be a promising candidate for its utilization as a sustained drug delivery system.

Hard Gelatin Capsules with Alginate-Hypromellose Microparticles as a Multicompartment Drug Delivery System for Sustained Posaconazole Release

Preparation and Evaluation of Posaconazole-Loaded Enteric Microparticles in Rats.

Preparation of Posaconazole Nanosponges for Improved Topical Delivery System

Gellan gum–based in situ gelling ophthalmic nanosuspension of Posaconazole

Empowering Topical Delivery: Box Behnken Design Optimization of Posaconazole Microsponge Hydrogel for Improved Management of Fungal Infections

Physicochemical and release studies of new mucoadhesive fluconazole delivery systems

Poly(vinylpyridine- co -vinylpyridine N -oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid Dispersions

Preparation and characterization of microcapsules based on biodegradable polymers: pectin/casein complex for controlled drug release systems

Formulation and Evaluation of Nanoemulgels for the Topical Drug Delivery of Posaconazole

Formulation, Statistical Optimization, and In Vivo Pharmacodynamics of Cydonia oblonga Mucilage/Alginate Mucoadhesive Microspheres for the Delivery of Metformin HCl

Amphiphilic Copolymer Brush with Random Ph-Sensitive/Hydrophobic Structure: Synthesis and Self-Assembled Micelles for Sustained Drug Delivery

Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin

Innovative Microencapsulation of Polymyxin B for Enhanced Antimicrobial Efficacy via Coated Spray Drying

RSM optimized chitosan based composite hydrogel for sustained drug delivery applications

Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes

Chitosan-Graft-Poly(N-Isopropylacrylamide)/PVA Cryogels as Carriers for Mucosal Delivery of Voriconazole

Alginate-based hybrid aerogel microparticles for mucosal drug delivery

Injectable Alginate Microsphere/plga–peg–plga Composite Hydrogels for Sustained Drug Release

Chemistry and Ionization of HPMCAS Influences the Dissolution and Solution-Mediated Crystallization of Posaconazole Amorphous Solid Dispersions

Preparation of injectable sodium alginate/poloxamer composite hydrogel for sustained drug release

Fabrication of Drug-Loaded Biodegradable Microcapsules for Controlled Release by Combination of Solvent Evaporation and Layer-by-layer Self-Assembly